OrthoPediatrics (NASDAQ:KIDS) Price Target Raised to $20.00

OrthoPediatrics (NASDAQ:KIDS) had its price objective raised by Truist Financial from $19.00 to $20.00 in a research report sent to investors on Monday, Marketbeat reports. They currently have a hold rating on the stock.

Other research analysts have also recently issued research reports about the company. Needham & Company LLC increased their price objective on OrthoPediatrics from $26.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 27th. BTIG Research raised their price target on shares of OrthoPediatrics from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, February 27th. TD Cowen raised shares of OrthoPediatrics to a “strong-buy” rating in a report on Tuesday, January 27th. Wall Street Zen lowered shares of OrthoPediatrics from a “hold” rating to a “sell” rating in a research report on Saturday, February 21st. Finally, Canaccord Genuity Group began coverage on shares of OrthoPediatrics in a research report on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.67.

OrthoPediatrics Stock Down 1.0%

OrthoPediatrics stock opened at $18.48 on Monday. The company’s 50-day moving average price is $17.72 and its two-hundred day moving average price is $18.13. The company has a quick ratio of 3.52, a current ratio of 7.40 and a debt-to-equity ratio of 0.28. The stock has a market cap of $463.48 million, a P/E ratio of -10.93 and a beta of 1.07. OrthoPediatrics has a twelve month low of $15.28 and a twelve month high of $26.40.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Thursday, February 26th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.37) by $0.11. The company had revenue of $61.61 million for the quarter, compared to the consensus estimate of $61.27 million. OrthoPediatrics had a negative return on equity of 6.68% and a negative net margin of 16.77%. As a group, analysts expect that OrthoPediatrics will post -0.93 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of KIDS. Millennium Management LLC boosted its holdings in shares of OrthoPediatrics by 48.0% during the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after acquiring an additional 452,840 shares in the last quarter. Prosight Management LP increased its holdings in OrthoPediatrics by 319.2% in the 3rd quarter. Prosight Management LP now owns 308,707 shares of the company’s stock worth $5,720,000 after purchasing an additional 235,060 shares in the last quarter. Deerfield Management Company L.P. raised its position in OrthoPediatrics by 1,153.4% in the third quarter. Deerfield Management Company L.P. now owns 194,109 shares of the company’s stock valued at $3,597,000 after purchasing an additional 178,623 shares during the last quarter. Nantahala Capital Management LLC boosted its stake in shares of OrthoPediatrics by 303.3% during the fourth quarter. Nantahala Capital Management LLC now owns 199,449 shares of the company’s stock valued at $3,542,000 after purchasing an additional 150,000 shares in the last quarter. Finally, RA Capital Management L.P. acquired a new stake in shares of OrthoPediatrics during the fourth quarter valued at about $1,953,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.